FDA Inspection
Children's Healthcare IRB #1Children's Healthcare IRB #1 – FDA Inspection, Jan 31, 2020
Record Details
This FDA Inspection record concerns Children's Healthcare IRB #1, with an inspection on January 31, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Children's Healthcare IRB #1
- Inspection Date
- January 31, 2020
- Product Type
- Drugs
View Company Profile
ID · fcd8c97a-8422-4aaa-a941-ef4f2698ccf9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1116412
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 56.115(a)(5)List of members
- 21 CFR 50.27(b)(2)Short form: Summary copy not signed/given
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(b)(1)Prompt reporting of unanticipated problems
- 21 CFR 56.110(b)Research not eligible for expedited review
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Children's Healthcare IRB #1
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2023 | VAI | Bioresearch Monitoring | |
| January 10, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Children's Healthcare IRB #1
- FDA Inspection 1196717 - 2023-02-03
- FDA Inspection 817882 - 2013-01-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.